The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Churg-Strauss syndrome
Abstract
Purpose To determine the association of antineutrophil cytoplasmic antibodies (ANCA) and leukotriene receptor antagonists with disease activity in a large series of patients with Churg-Strauss syndrome.Methods Potential subjects were identified by a computerized search of the Mayo Clinic Rochester database for the years 1990 to 2000. Patients meeting one of three classification schemes for Churg-Strauss syndrome were included.Results Ninety-one patients met the inclusion criteria. Clinical manifestations were similar to those in previous reports. Mortality was similar to that in the general population. ANCA testing was performed in 74 patients. Seventy-three percent (n = 22) of the 30 patients tested before therapy were ANCA positive, as were 75% (n = 12) of the 16 patients tested during a disease flare. In comparison, 16% (n = 8) of the 49 tested during remission were ANCA positive. Serial measurements indicated a correlation of ANCA levels with disease activity. Central nervous system involvement was the only clinical manifestation that correlated with ANCA status (P = 0.05). Twenty-three patients received leukotriene receptor antagonists, of whom 16 (70%) began treatment before diagnosis and 6 (27%) began during remission. Two of those treated after diagnosis relapsed. In 1 patient the relation between disease and leukotriene receptor antagonist use could not be determined. Use of leukotriene receptor antagonists did not affect the time between onset of asthma and manifestations of vasculitis, and was not correlated with organ manifestations, except sinus disease.Conclusion No one classification scheme identified all patients. Churg-Strauss syndrome has a better prognosis than other ANCA-associated vasculitides. ANCA status correlates with disease activity, whereas a pathogenic role for leukotriene receptor antagonists in the development of Churg-Strauss syndrome was not noted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rhinitis (75% of patients) is one of the initial manifestations of EGPA,248 in addition to CRS with nasal polyps (CRSwNP), and partial/total smell loss.249”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [249]
Citations
Cites
Nomenclature of Systemic Vasculitides
Jennette, J. C., Falk, R. J., Andrassy, K., Bacon, P. A., Churg, J., Gross, W. L., Hagen, E. C., Hoffman, G. S., Hunder, G. G., Kallenberg, C. G. M., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370206 · Cited by 3,845
Wegener Granulomatosis: An Analysis of 158 Patients
Hoffman, G. S., Kerr, G. S., Leavitt, R. Y., Hallahan, C. W., Lebovics, R. S., Travis, W. D., Rottem, M., & Fauci, A. S. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-6-488 · Cited by 2,857
Masi, A. T., Hunder, G. G., Lie, J. T., Michel, B. A., Bloch, D. A., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330806 · Cited by 2,215
Allergic granulomatosis, allergic angiitis, and periarteritis nodosa.
Churg, J., & Strauss, L. (1951) · PubMed · Cited by 1,696
Systemic Vasculitis with Asthma and Eosinophilia: A Clinical Approach to the Churg-Strauss Syndrome
LANHAM, J. G., ELKON, K. B., PUSEY, C. D., & HUGHES, G. R. (1984) · Medicine · doi:10.1097/00005792-198403000-00001 · Cited by 1,238
Churg-Strauss Syndrome Clinical Study and Long-Term Follow-Up of 96 Patients
Guillevin, L., Cohen, P., Gayraud, M., Lhote, F., Jarrousse, B., & Casassus, P. (1999) · Medicine · doi:10.1097/00005792-199901000-00003 · Cited by 1,074
Guillevin, L., Lhote, F., Gayraud, M., Cohen, P., Jarrousse, B., Lortholary, O., Thibult, N., & Casassus, P. (1996) · Medicine · doi:10.1097/00005792-199601000-00003 · Cited by 1,000
Characterization of the human cysteinyl leukotriene CysLT1 receptor
Lynch, K. R., O'Neill, G. P., Liu, Q., Im, D.-S., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z., et al. (1999) · Nature · doi:10.1038/21658 · Cited by 965
Microscopic polyangiitis: Clinical and laboratory findings in eighty-five patients
Guillevin, L., Durand-Gasselin, B., Cevallos, R., Gayraud, M., Lhote, F., Callard, P., Amouroux, J., Casassus, P., & Jarrousse, B. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:3<421::aid-anr5>3.0.co;2-6 · Cited by 823
Reinhold-Keller, E., Beuge, N., Latza, U., De Groot, K., Rudert, H., Nölle, B., Heller, M., & Gross, W. L. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1021::aid-anr10>3.0.co;2-j · Cited by 696
Research works printed but not linked: 1
- Watts, 2000, Epidemiology of systemic vasculitis, Arthritis Rheum, 43, 414, 10.1002/1529-0131(200002)43:2<414::aid-anr23>3.0.co;2-0 · doi:10.1002/1529-0131(200002)43:2<414::aid-anr23>3.0.co;2-0
Cited by
Comarmond, C., Pagnoux, C., Khellaf, M., Cordier, J., Hamidou, M., Viallard, J., Maurier, F., Jouneau, S., Bienvenu, B., Puéchal, X., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37721 · Cited by 937
“Three of the 108 ANCApositive patients had both perinuclear and cytoplasmic labeling patterns on IF, with 1 being both MPO-positive and PR3-positive on ELISA.”
BackgroundInfluentialSinico, R. A., Di Toma, L., Maggiore, U., Bottero, P., Radice, A., Tosoni, C., Grasselli, C., Pavone, L., Gregorini, G., Monti, S., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21250 · Cited by 691
Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome
Sablé-Fourtassou, R., Cohen, P., Mahr, A., Pagnoux, C., Mouthon, L., Jayne, D., Blockmans, D., Cordier, J.-F., Delaval, P., Puechal, X., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-9-200511010-00006 · Cited by 688
“Mean (SD) age [range], y 54 (14) 51 (15) 52 (15) [18–79] Men/women, n/n 21/22 34/35 55/57 Clinical symptoms Mean (SD) weight loss, kg 9 (9) 7 (7) 8 (8) Fever, n (%) 13 (30) 38 (55) 51 (45) Myalgia, n (%) 25 (58) 35 (51) 60 (54) Arthralgia, n (%) 18 (42) 24 (35) 42 (37) Ear–nose–throat symptoms, n (%)† 36 (86) 47 (71)…”
BackgroundInternational Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Groh, M., Pagnoux, C., Baldini, C., Bel, E., Bottero, P., Cottin, V., Dalhoff, K., Dunogué, B., Gross, W., Holle, J., et al. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.04.022 · Cited by 476
“ANCA-positivity ranges from 30–70% of EGPA patients but is usually less frequently observed than in other AAV [3–7].”
BackgroundSelf-citation
Metadata
- Authors
- Keogh, K. A., & Specks, U.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Specks, Ulrich
- ORCID
- Specks, Ulrich
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 115
- Issue
- 4
- Pages
- 284-290
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W2011779958
- Cited by
- 290
- References
- 52
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 5 · 2023: 11 · 2022: 10 · 2021: 7 · 2020: 11 · 2019: 14 · 2018: 8 · 2017: 6 · 2016: 13 · 2015: 15 · 2014: 11 · 2013: 23 · 2012: 24
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Keywords
- eosinophilic granulomatosis with polyangiitis, antineutrophil cytoplasmic antibodies, leukotriene receptor antagonists, disease activity, vasculitis, asthma, central nervous system involvement, disease classification, prognosis, relapse
- MeSH terms
- Acetates, Adolescent, Adult, Aged, Asthma, Biopsy, Central Nervous System Diseases, Child, Cyclopropanes, Electromyography, Eosinophilic Granuloma, Female, Follow-Up Studies, Glucocorticoids, Humans, Immunosuppressive Agents, Indoles, Male, Middle Aged, Minnesota, Peroxidase, Predictive Value of Tests, Quinolines, Statistics as Topic, Sulfides, Sulfonamides, Tosyl Compounds, Churg-Strauss Syndrome, Survival Analysis, Treatment Outcome, Antibodies, Antineutrophil Cytoplasmic, Leukotriene Antagonists, Phenylcarbamates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Churg-Strauss syndrome. https://app.cochat.ai/papers/10.1016/s0002-9343(03)00359-0
- The paper
- Keogh, K. A., & Specks, U. (2003). Churg-Strauss syndrome. The American Journal of Medicine. https://doi.org/10.1016/s0002-9343(03)00359-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.